EBV-infected B cells in infectious mononucleosis: Viral strategies for spreading in the B cell compartment and establishing latency

Immunity

Volumn 13, Issue 4, 2000, Pages 485-495

  Kurth, Julia ^a   Spieker, Tilmann ^b   Wustrow, Jochen ^c   Strickler, John G ^d   Hansmann, Martin Leo ^b   Rajewsky, Klaus ^a   Küppers, Ralf ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c St Elisabeth Hospital   (Germany)

^d Allina Hospitals & Clinics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENE REARRANGEMENT; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN GENE; INFECTIOUS MONONUCLEOSIS; MALE; MEMORY CELL; PRIORITY JOURNAL; TONSIL; VIRUS GENE; VIRUS LATENCY;

EID: 0033680735     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)00048-0     Document Type: Article

References (53)

1. Early events in Epstein-Barr virus infection of human B lymphocytes
2. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: Implications for the interindividual infection route of Epstein-Barr virus
3. Frequent expansion of Epstein-Barr virus (EBV) infected cells In germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma
4. EBV persistence in memory B cells in vivo
5. The expression of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell
6. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells
7. Molecular analysis of single B cells from T cell-rich B cell lymphoma reveals the derivation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells
8. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals
9. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis
10. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo
11. Probing the human B-cell repertoire with EBV: Polyreactive antibodies and CD5+ B lymphocytes
12. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1
13. Effect of a herpes group virus (EBV) on growth of peripheral leukocyte cultures
14. Epstein-Barr virus genomes are found predominantly in IgA-positive B cells in the blood of healthy carriers
15. Frequent occurrence of deletions and duplications during somatic hypermutation: Implications for oncogene translocations and heavy chain disease
16. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis
17. Epstein-Barr virus latent membrane protein expression by Hodgkin and Reed-Sternberg-like cells in acute infectious mononucleosis
18. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells
19. Hodgkin and Reed-Sternberg-like cells in B cell chronic lymphocytic eukemia represent the out-growth of single germinal-center B cell-derived cones potential precursors of Hodgkin and Reed-Steinberg cells in Hodgkin's disease?
20. Epstein-Barr virus and its replication
21. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulated an activated CD40 receptor
22. Somatic hypermutation in normal and transformed human B cells
23. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells
24. Expression of the Epstein-Barr virus latent membrane protein I induces B cell lymphoma in transgenic mice
25. Micromanipulation and PCR analysis of single cells from tissue sections
26. The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease
27. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections
28. Germinal center founder cells display propensity for apoptosis before onset of somatic mutation
29. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell
30. A novel form of Epstein-Barr virus latency in normal B cells in vivo
31. Infectious mononucleosis and Hodgkin's disease
32. Epstein-Barr virus infection in oral hairy leukoplakia: Virus replication in the absence of a detectable latent phase
33. Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue
34. Epstein-Barr virus (EBV) infection in infectious mononucleosis: Virus latency, replication and phenotype of EBV-infected cells
35. Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis
36. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes
37. Clonal selection and learning in the antibody system
38. New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease
39. Epstein-Barr virus
40. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells
41. Quantitative evaluation of Epstein-Barr-virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis
42. Hodgkin's disease in patients with previous infectious mononucleosis: 30 years' experience
43. Epstein-Barr virus replication in oropharyngeal epithelial cells
44. Visualization of alternative Epstein-Barr virus expression programs by fluorescent in situ hybridization at the cell level
45. Epstein-Barr virus and the B cell: That's all it takes
46. Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state
47. Epstein-Barr virus-infected T cells in infectious mononucleosis
48. Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis
49. Mimicry of CD40 signals by Epstein-Barr Virus LMP1 in B lymphocyte response
50. Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction
51. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23
52. Whole genome amplification from a single cell: Implication for genetic analysis
53. Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival